ResApp Health Limited (RAP) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware. On 23 August 2019, the Company announced that its first commercial product, ResAppDx-EU, has received CE Mark certification as a Class IIa medical device.
ResApp Health Limited belongs to Health Care sector and under industry of Health Care Technology. You can get more information about this company via their website: http://www.resapphealth.com.au.
This a small cap company with market cap of 51 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.
Dividend Growth Chart
The following chart shows you how rap dividend grows in the recent years.